Find News

Filter articles

Applied Filters

Showing 111 to 120 of 1068 results

Fed Circuit split over $235m skinny label verdict

US10-08-2021Rory O'Neill

The US Court of Appeals for the Federal Circuit has reinstated a $235 million verdict against Teva in a split decision which could have major implications for skinny label generics.

Shionogi and Duchesnay add new patents to Osphena dispute

US05-08-2021Alex Baldwin

Pharmaceutical companies Shionogi and Duchesnay have filed a second lawsuit against Hetero labs, claiming that the company infringed two additional patents related to Osphena—a treatment for vaginal pain during sex.

Takeda faces ‘pay-for-delay’ class-action suit over anti-constipation drug

US05-08-2021Alex Baldwin

Takeda Pharmaceuticals is the target of a proposed class action that alleges the pharma giant paid to keep a generic anti-constipation drug off the market.

FDA approves milestone biosimilar insulin drug


The US Food and Drug Administration has approved the first-ever interchangeable biosimilar product, an insulin treatment for Types 1 and 2 diabetes.

AstraZeneca loses major generics appeal in India

India22-07-2021Rory O'Neill

The Delhi High Court has cleared the way for a slew of generic diabetes drugs to arrive on the Indian market after it rejected AstraZeneca’s request for a blocking order.

CMA fines drugmakers £260m for 10,000% price hike


The UK’s Competition and Markets Authority has imposed fines of £260 million on drug companies for raising the price of life-saving hydrocortisone tablets by 10,000%.

POTUS orders crackdown on anticompetitive drug practices

US13-07-2021Alex Baldwin

An executive order by President Joe Biden has targeted anti-competitive practices in the US drugs market, including a ban of pay-for-delay agreements.

Taiwanese biotech built on ‘foundation of lies’, says DoJ

08-07-2021Rory O'Neill

US prosecutors have charged the founders of Taiwanese biosimilar manufacturer JHL Biotech with stealing Genentech trade secrets.

Teva sues two Indian generics over Huntington’s treatment

India, US06-07-2021Alex Baldwin

Teva Pharmaceuticals has filed lawsuits in New Jersey against two Indian generics manufacturers to stop them from developing a generic version of its Huntington’s disease treatment.

UK Supreme Court shoots down NHS £220m drug patent suit

UK02-07-2021Alex Baldwin

The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.

Showing 111 to 120 of 1068 results